• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

How To Manage T3b Prostate Cancer in the Contemporary Era: Referee Position.

作者信息

Bossi Alberto, Dariane Charles, Sargos Paul

机构信息

Amethyst Radiotherapy Group, La Garenne Colombes, France.

Department of Urology, Hôpital européen Georges-Pompidou, AP-HP, Paris, France.

出版信息

Eur Urol Open Sci. 2023 May 29;53:58-59. doi: 10.1016/j.euros.2023.05.010. eCollection 2023 Jul.

DOI:10.1016/j.euros.2023.05.010
PMID:37287635
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10241841/
Abstract
摘要

相似文献

1
How To Manage T3b Prostate Cancer in the Contemporary Era: Referee Position.当代如何管理T3b期前列腺癌：裁判立场
Eur Urol Open Sci. 2023 May 29;53:58-59. doi: 10.1016/j.euros.2023.05.010. eCollection 2023 Jul.
2
How To Manage T3b Prostate Cancer in the Contemporary Era: Is Radiotherapy the Standard of Care?当代如何管理T3b期前列腺癌：放射治疗是标准治疗方法吗？
Eur Urol Open Sci. 2023 May 29;53:60-62. doi: 10.1016/j.euros.2023.05.009. eCollection 2023 Jul.
3
How To Manage T3b Prostate Cancer in the Contemporary Era: The Benefits of Surgery.当代如何管理T3b期前列腺癌：手术的益处
Eur Urol Open Sci. 2023 May 29;53:55-57. doi: 10.1016/j.euros.2023.05.004. eCollection 2023 Jul.
4
Impact of five-tiered Gleason grade groups on prognostic prediction in clinical stage T3 prostate cancer undergoing high-dose-rate brachytherapy.五级 Gleason 分级组对接受高剂量率近距离放疗的临床分期 T3 前列腺癌预后预测的影响。
Prostate. 2017 Nov;77(15):1520-1527. doi: 10.1002/pros.23430. Epub 2017 Sep 14.
5
Risk of adverse pathology at prostatectomy in the era of MRI and targeted biopsies; rethinking active surveillance for intermediate risk prostate cancer patients.在 MRI 和靶向活检时代前列腺切除术的不良病理风险；重新思考中危前列腺癌患者的主动监测。
Urol Oncol. 2021 Oct;39(10):729.e1-729.e6. doi: 10.1016/j.urolonc.2021.02.018. Epub 2021 Mar 16.
6
Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.在前列腺特异性抗原时代，性类固醇激素、雄激素受体基因CAG重复序列与前列腺癌后续风险
Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1262-9. doi: 10.1158/1055-9965.EPI-04-0371.
7
Match Analysis of Soccer Refereeing Using Spatiotemporal Data: A Case Study.基于时空数据的足球裁判判罚分析：案例研究。
Sensors (Basel). 2021 Apr 5;21(7):2541. doi: 10.3390/s21072541.
8
Referee: Reference Assembly Quality Scores.评审员：参考组装质量评分。
Genome Biol Evol. 2019 May 1;11(5):1483-1486. doi: 10.1093/gbe/evz088.
9
Role of Brachytherapy Boost in Clinically Localized Intermediate and High-Risk Prostate Cancer: Lack of Benefit in Patients with Very High-Risk Factors T3b-4 and/or Gleason 9-10.近距离放疗加量在临床局限性中高危前列腺癌中的作用：对具有T3b - 4和/或Gleason 9 - 10等极高风险因素患者无益处。
Cancers (Basel). 2022 Jun 16;14(12):2976. doi: 10.3390/cancers14122976.
10
Is the GPSM scoring algorithm for patients with prostate cancer valid in the contemporary era?用于前列腺癌患者的GPSM评分算法在当代是否有效？
J Urol. 2007 Aug;178(2):459-63; discussion 463. doi: 10.1016/j.juro.2007.03.124. Epub 2007 Jun 11.

本文引用的文献

1
NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023.NCCN 指南®洞察：前列腺癌，第 1.2023 版。
J Natl Compr Canc Netw. 2022 Dec;20(12):1288-1298. doi: 10.6004/jnccn.2022.0063.
2
Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022.晚期前列腺癌患者的管理。第一部分：中高危和局部进展性疾病、生化复发和激素治疗的副作用：2022 年晚期前列腺癌共识会议报告。
Eur Urol. 2023 Mar;83(3):267-293. doi: 10.1016/j.eururo.2022.11.002. Epub 2022 Dec 6.
3
Characteristics of Patients in SPCG-15-A Randomized Trial Comparing Radical Prostatectomy with Primary Radiotherapy plus Androgen Deprivation Therapy in Men with Locally Advanced Prostate Cancer.SPCG-15-A随机试验中局部晚期前列腺癌男性患者的特征：根治性前列腺切除术与原发性放疗加雄激素剥夺疗法的比较
Eur Urol Open Sci. 2022 May 26;41:63-73. doi: 10.1016/j.euros.2022.04.013. eCollection 2022 Jul.
4
Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts.雄激素剥夺治疗持续时间与外照射放疗联合或不联合近距离放疗治疗高危前列腺癌的最佳治疗效果的相互作用：3 个队列的患者水平数据分析。
JAMA Oncol. 2022 Mar 1;8(3):e216871. doi: 10.1001/jamaoncol.2021.6871. Epub 2022 Mar 17.
5
Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.醋酸阿比特龙和泼尼松与或不与恩扎卢胺用于高危非转移性前列腺癌：来自 STAMPEDE 平台方案两项随机对照 3 期试验主要结果的荟萃分析。
Lancet. 2022 Jan 29;399(10323):447-460. doi: 10.1016/S0140-6736(21)02437-5. Epub 2021 Dec 23.
6
Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features.高危前列腺癌伴不良临床病理特征患者的多模式治疗比较及结果。
JAMA Netw Open. 2021 Jul 1;4(7):e2115312. doi: 10.1001/jamanetworkopen.2021.15312.
7
Adjuvant Versus Early Salvage Radiation Therapy for Men at High Risk for Recurrence Following Radical Prostatectomy for Prostate Cancer and the Risk of Death.辅助治疗与早期挽救性放疗在前列腺癌根治术后高复发风险男性中的应用及其与死亡风险的关系。
J Clin Oncol. 2021 Jul 10;39(20):2284-2293. doi: 10.1200/JCO.20.03714. Epub 2021 Jun 4.
8
Multiparametric Magnetic Resonance Imaging Should Be Preferred Over Digital Rectal Examination for Prostate Cancer Local Staging and Disease Risk Classification.多参数磁共振成像应优于数字直肠检查，用于前列腺癌局部分期和疾病风险分类。
Urology. 2021 Jan;147:205-212. doi: 10.1016/j.urology.2020.08.089. Epub 2020 Oct 28.
9
Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data.辅助或早期挽救性放疗治疗局限性和局部进展性前列腺癌：汇总数据的前瞻性计划系统评价和荟萃分析。
Lancet. 2020 Oct 31;396(10260):1422-1431. doi: 10.1016/S0140-6736(20)31952-8. Epub 2020 Sep 28.
10
Impact of Magnetic Resonance Imaging on Prostate Cancer Staging and European Association of Urology Risk Classification.磁共振成像对前列腺癌分期和欧洲泌尿外科学会风险分类的影响。
Urology. 2019 Aug;130:113-119. doi: 10.1016/j.urology.2019.04.023. Epub 2019 Apr 30.